Comparison of mean differences in temperature decreases. حسب Hans-Jörg Gillmann (8460585)

Decreasing mean transistor size since 2000. حسب David Burg (8209752)

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

LGP2 overexpression decreases the transcript levels of the IFN signaling and proinflammatory cytokines during ZIKV infection. حسب Zhongyuan Tan (5779016)

Comparison of ∑PCDD/F, PCDD/F TEQ, ∑PCB, PCB TEQ and ∑TEQ concentrations in eggs analyzed in this study and other relevant studies (pg/g ww except for ∑PCB ng/g ww, geometric mean... حسب Matti Viluksela (321291)

TPP decreases melanoma tumor growth rate when administered via hydrogel. حسب Kyle C. Kloepping (9928265)

Comparison hourly means of wind speeds from 19 wind observation stations with ERA5 reanalysis wind data in the China’s offshore water. حسب Weidong Ji (129916)

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. حسب Alejandro Piscoya (782326)

Preoperative and postoperative scores for the different dimensions of BAROS scores in groups A, B, C D, E, F, and G. حسب Régis Cohen (11419436)

الموضوعات:

Self-reporting questionnaire for employement. حسب Régis Cohen (11419436)

الموضوعات:

Preoperative and postoperative questionnaire scores of groups A, B, C, D, E, F, and G. حسب Régis Cohen (11419436)

الموضوعات:

Preoperative baseline characteristics of the population (n = 133). حسب Régis Cohen (11419436)

الموضوعات:

Satisfaction scale. حسب Régis Cohen (11419436)

الموضوعات:

BAROS questionnaire. حسب Régis Cohen (11419436)

الموضوعات:

Self-monitoring questionnaire used to evaluate deprivation status (EPICES score). حسب Régis Cohen (11419436)

الموضوعات:

Flowchart of study selection. حسب Alejandro Piscoya (782326)

Description of characteristics of included studies. حسب Alejandro Piscoya (782326)

Effect of remdesivir on invasive ventilation at 14 days. حسب Alejandro Piscoya (782326)

Effect of remdesivir on all-cause mortality at 14 days. حسب Alejandro Piscoya (782326)

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)